Item 9 Labs Corp. (INLB)

Market Cap	702.00 -100.0%
Revenue (ttm)	19.69M -17.4%
Net Income	-31.03M
EPS	-0.32
Shares Out	701.81M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	418
Average Volume	5,745
Open	0.0000
Previous Close	0.0000
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0000
Beta	0.15
RSI	25.80
Earnings Date	n/a

About Item 9 Labs

Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. It operates through Cultivation, Franchising, and Corporate segments. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Employees: 104
• Stock Exchange: OTCMKTS
• Ticker Symbol: INLB

Financial Performance

In fiscal year 2022, Item 9 Labs's revenue was $21.76 million, a decrease of -0.82% compared to the previous year's $21.94 million. Losses were -$31.14 million, 185.6% more than in 2021.